336 related articles for article (PubMed ID: 26909323)
1. The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity.
Kraehenmann R; Schmidt A; Friston K; Preller KH; Seifritz E; Vollenweider FX
Neuroimage Clin; 2016; 11():53-60. PubMed ID: 26909323
[TBL] [Abstract][Full Text] [Related]
2. Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination.
Grimm O; Kraehenmann R; Preller KH; Seifritz E; Vollenweider FX
Eur Neuropsychopharmacol; 2018 Jun; 28(6):691-700. PubMed ID: 29703645
[TBL] [Abstract][Full Text] [Related]
3. Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.
Bernasconi F; Schmidt A; Pokorny T; Kometer M; Seifritz E; Vollenweider FX
Cereb Cortex; 2014 Dec; 24(12):3221-31. PubMed ID: 23861318
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.
Mertens LJ; Wall MB; Roseman L; Demetriou L; Nutt DJ; Carhart-Harris RL
J Psychopharmacol; 2020 Feb; 34(2):167-180. PubMed ID: 31941394
[TBL] [Abstract][Full Text] [Related]
5. Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.
Kraehenmann R; Preller KH; Scheidegger M; Pokorny T; Bosch OG; Seifritz E; Vollenweider FX
Biol Psychiatry; 2015 Oct; 78(8):572-81. PubMed ID: 24882567
[TBL] [Abstract][Full Text] [Related]
6. The role of serotonin in the neurocircuitry of negative affective bias: serotonergic modulation of the dorsal medial prefrontal-amygdala 'aversive amplification' circuit.
Robinson OJ; Overstreet C; Allen PS; Letkiewicz A; Vytal K; Pine DS; Grillon C
Neuroimage; 2013 Sep; 78():217-23. PubMed ID: 23583742
[TBL] [Abstract][Full Text] [Related]
7. Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.
Stoliker D; Novelli L; Vollenweider FX; Egan GF; Preller KH; Razi A
Biol Psychiatry; 2024 Jul; 96(1):57-66. PubMed ID: 38185235
[TBL] [Abstract][Full Text] [Related]
8. Impaired prefrontal-amygdala effective connectivity is responsible for the dysfunction of emotion process in major depressive disorder: a dynamic causal modeling study on MEG.
Lu Q; Li H; Luo G; Wang Y; Tang H; Han L; Yao Z
Neurosci Lett; 2012 Aug; 523(2):125-30. PubMed ID: 22750155
[TBL] [Abstract][Full Text] [Related]
9. fMRI neurofeedback of amygdala response to aversive stimuli enhances prefrontal-limbic brain connectivity.
Paret C; Ruf M; Gerchen MF; Kluetsch R; Demirakca T; Jungkunz M; Bertsch K; Schmahl C; Ende G
Neuroimage; 2016 Jan; 125():182-188. PubMed ID: 26481674
[TBL] [Abstract][Full Text] [Related]
10. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.
Kometer M; Schmidt A; Bachmann R; Studerus E; Seifritz E; Vollenweider FX
Biol Psychiatry; 2012 Dec; 72(11):898-906. PubMed ID: 22578254
[TBL] [Abstract][Full Text] [Related]
11. Cannabinoid modulation of amygdala subregion functional connectivity to social signals of threat.
Gorka SM; Fitzgerald DA; de Wit H; Phan KL
Int J Neuropsychopharmacol; 2014 Dec; 18(3):. PubMed ID: 25548107
[TBL] [Abstract][Full Text] [Related]
12. Age-related changes in amygdala-frontal connectivity during emotional face processing from childhood into young adulthood.
Wu M; Kujawa A; Lu LH; Fitzgerald DA; Klumpp H; Fitzgerald KD; Monk CS; Phan KL
Hum Brain Mapp; 2016 May; 37(5):1684-95. PubMed ID: 26931629
[TBL] [Abstract][Full Text] [Related]
13. Emotions and brain function are altered up to one month after a single high dose of psilocybin.
Barrett FS; Doss MK; Sepeda ND; Pekar JJ; Griffiths RR
Sci Rep; 2020 Feb; 10(1):2214. PubMed ID: 32042038
[TBL] [Abstract][Full Text] [Related]
14. The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.
Kometer M; Cahn BR; Andel D; Carter OL; Vollenweider FX
Biol Psychiatry; 2011 Mar; 69(5):399-406. PubMed ID: 21126732
[TBL] [Abstract][Full Text] [Related]
15. Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.
Lee HJ; Tsang VW; Chai BS; Lin MC; Howard A; Uy C; Elefante JO
J Psychoactive Drugs; 2024; 56(3):301-315. PubMed ID: 37385217
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid Administration Improves Aberrant Fear-Processing Networks in Spider Phobia.
Nakataki M; Soravia LM; Schwab S; Horn H; Dierks T; Strik W; Wiest R; Heinrichs M; de Quervain DJ; Federspiel A; Morishima Y
Neuropsychopharmacology; 2017 Jan; 42(2):485-494. PubMed ID: 27644128
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal-Amygdala Dysregulation to Threat in Pediatric Posttraumatic Stress Disorder.
Wolf RC; Herringa RJ
Neuropsychopharmacology; 2016 Feb; 41(3):822-31. PubMed ID: 26171717
[TBL] [Abstract][Full Text] [Related]
18. Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.
Pokorny T; Preller KH; Kraehenmann R; Vollenweider FX
Eur Neuropsychopharmacol; 2016 Apr; 26(4):756-66. PubMed ID: 26875114
[TBL] [Abstract][Full Text] [Related]
19. Medial prefrontal dysfunction and prolonged amygdala response during instructed fear processing in borderline personality disorder.
Kamphausen S; Schröder P; Maier S; Bader K; Feige B; Kaller CP; Glauche V; Ohlendorf S; Tebartz van Elst L; Klöppel S; Jacob GA; Silbersweig D; Lieb K; Tüscher O
World J Biol Psychiatry; 2013 May; 14(4):307-18, S1-4. PubMed ID: 22404662
[TBL] [Abstract][Full Text] [Related]
20. Neuroticism modulates amygdala-prefrontal connectivity in response to negative emotional facial expressions.
Cremers HR; Demenescu LR; Aleman A; Renken R; van Tol MJ; van der Wee NJ; Veltman DJ; Roelofs K
Neuroimage; 2010 Jan; 49(1):963-70. PubMed ID: 19683585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
